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Abstract
The cellular ontogeny of hematopoietic stem cells (HSCs) remains poorly understood because their isolation from and their
identification in early developing small embryos are difficult. We attempted to dissect early developmental stages of HSCs
using an in vitro mouse embryonic stem cell (ESC) differentiation system combined with inducible HOXB4 expression. Here
we report the identification of pre-HSCs and an embryonic type of HSCs (embryonic HSCs) as intermediate cells between
ESCs and HSCs. Both pre-HSCs and embryonic HSCs were isolated by their c-Kit
+CD41
+CD45
2 phenotype. Pre-HSCs did not
engraft in irradiated adult mice. After co-culture with OP9 stromal cells and conditional expression of HOXB4, pre-HSCs gave
rise to embryonic HSCs capable of engraftment and long-term reconstitution in irradiated adult mice. Blast colony assays
revealed that most hemangioblast activity was detected apart from the pre-HSC population, implying the early divergence
of pre-HSCs from hemangioblasts. Gene expression profiling suggests that a particular set of transcripts closely associated
with adult HSCs is involved in the transition of pre-HSC to embryonic HSCs. We propose an HSC developmental model in
which pre-HSCs and embryonic HSCs sequentially give rise to adult types of HSCs in a stepwise manner.
Citation: Matsumoto K, Isagawa T, Nishimura T, Ogaeri T, Eto K, et al. (2009) Stepwise Development of Hematopoietic Stem Cells from Embryonic Stem Cells. PLoS
ONE 4(3): e4820. doi:10.1371/journal.pone.0004820
Editor: Catherine M. Verfaillie, KU Leuven, Belgium
Received November 5, 2008; Accepted January 31, 2009; Published March 16, 2009
Copyright:  2009 Matsumoto et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the Ministry of Education, Culture, Sport, Science, and Technology, Japan. These grants have no financial
interests, and played no role in study and preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nakauchi@ims.u-tokyo.ac.jp (HN); hema@ims.u-tokyo.ac.jp (HE)
Introduction
Mammalian hematopoiesis develops in three distinct waves
consisting of primitive hematopoiesis, definitive but transient
hematopoiesis, and definitive and persistent hematopoiesis which
is established by hematopoietic stem cells (HSCs) [1,2]. Both the
first and second hematopoietic waves originate from the yolk sac
where hemangioblasts, common precursors of the hematopoietic
and endothelial lineages likely play a crucial role [3]. However,
whether HSCs arise in either the yolk sac or the paraaortic
splanchnopleure/aorta-gonad-mesonephros (P-Sp/AGM) region
remains controversial [4,5,6]. The relationship between HSCs and
hemangioblasts is also obscure [2,7]. In order to understand how
HSCs develop in early embryos, it is important to determine the
cellular origin of HSCs rather than the organ origin of HSCs.
Hematopoiesis and vasculogenesis in the early mouse embryo
have been recapitulated well by in vitro ES differentiation systems
[8,9,10]. However, generation of HSCs in substantial numbers
from ESCs in vitro has been difficult. Kyba et al. were the first to
report that HSCs can be efficiently generated from ESCs in the
OP9 co-culture system by combining this with an inducible
HOXB4 expression system (OP9 and iHOXB4 system) [11].
In concept, mesodermal cells first commit to the hematopoietic
lineage before giving rise to HSCs. We provisionally called such
cells pre-HSCs, and attempted to identify them in embryoid
bodies (EB) using the OP9 and iHOXB4 system. We detected the
potential to give rise to HSCs among c-Kit
+CD41
+CD45
2 cells
derived from ESCs on day 6 of culture (EB6). The presence of
hematopoietic progenitor activity in this population has been
described [12,13,14]. The present report, however, is the first to
document the presence of pre-stem cell activity but little
hemangioblast activity in the c-Kit
+CD41
+CD45
2 cell population.
Pre-HSCs gave to an embryonic type of HSCs (embryonic
HSCs) capable of reconstituting adult hematopoietic system but at
a low degree. OP9 cells supported the transition of pre-HSCs to
embryonic HSCs. Some genes were up- and down-regulated
during the transition via enforced expression of HOXB4.
Interestingly, about two-thirds of the markedly up-regulated genes
were also found in our adult HSCs gene expression data. These
results suggest that adult HSC-related molecules establish the very
early stages of HSC development. Based on these results, we
propose an HSC development model in which pre-HSCs through
the stage of embryonic HSCs give rise to adult types of HSCs.
Results
Experimental design
Our basic experimental strategy consisted of EB formation, co-
culture with OP9 cells, and functional assays(Fig. 1). iHOXB4 ESCs
were allowed to differentiate spontaneously into EBs for 6 days
without HOXB4 expression. We decided to fractionate EB6 cells
mainly because by day 6 of culture the number of multipotent
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detectable (Fig. S1). CD41 is known as a marker for the initiation of
definitive hematopoiesis [15,16,17,18,19]. As shown in Fig. S1,
CD41 appeared in a significant proportion of EB cells on day 6 of
culture. Induced HOXB4 expression during EB formation did not
affectthe generation of colony forming cells and repopulating cells in
the OP9 and iHOXB4 system or the appearance of surface markers
in EB cells. EB6 cells were analyzed and sorted by flow cytometry.
Sorted EB6 cells were co-cultured with OP9 cells for various days
under HOXB4-on or -off conditions. The minimal requirement of
the co-culture period appeared to be only 4 days (data not shown),
which is much shorter than previously thought [11]. After a second
analysis and fractionation by flow cytometry, cells were subjected to
in vivo repopulating assays under HOXB4-on or -off conditions.
The potential to give rise to HSCs in EB6 subpopulations
EB6 cells were stained with anti-CD41 antibody in combination
with anti-CD45, -c-Kit, and -CD34 antibodies and others, and
analyzed by flow cytometry (Fig. 2A). CD41
+ and CD41
2 cells, c-
Kit
+CD41
+ and c-Kit
2CD41
+ cells, or CD34
+CD41
+ and
CD34
2CD41
+ cells were sorted by flow cytometry. Sorted cells
were co-cultured with OP9 cells for 4 days, and then transplanted
into lethally irradiated mice along with rescue cells (Table S1)
while HOXB4 expression was maintained from in vitro co-culture
through in vivo repopulation.
Analysis of peripheral blood cells of the recipient mice 16 weeks
after transplantation showed that c-Kit
+CD41
+ cells were enriched
in cells with long-term repopulating activity (Fig. 2B). Long-term
repopulating activity was similarly detected in both CD34
2 and
CD34
+ cells. Lineage analysis of reconstituted mice showed that
myeloid lineage reconstitution predominated. A very low level of
B- and T-lymphoid lineage reconstitution was observed only in
limited cases. As previously suggested, this might be due to an
adverse effect of HOXB4 overexpression [11]. For long-term
repopulation, HOXB4 needed to be expressed during the OP9 co-
culture period and throughout the repopulation period (data not
shown). All these data clearly show that c-Kit
+CD41
+ cells are the
cells that require HOXB4 expression to manifest long-term
repopulating activity. In addition, it should be emphasized that
CD45 is not expressed in these cells (Fig. 2A).
Hemangioblasts in EB6 subpopulations
To examine whether c-Kit
+CD41
+ cells have hemangioblastic
activity, we performed blast colony-forming cell (BL-CFC) assays [3]
on EB6 cells under HOXB4-off or -on conditions. Unexpectedly, c-
Kit
+CD41
+ cells exhibited scant BL-CFC activity, and c-Kit
+CD41
2
cells instead were significantly enriched in BL-CFC, regardless of
HOXB4 expression status (Fig. 3A). The potentials to give rise to
blood cells and vascular endothelial cells in BL-CFC were examined
on a clonal basis as previously described [20]. Most of these blast
colonies individually exhibited hematopoietic and/or endothelial
differentiation potential (Fig. S2). Of note is that neither BL-CFCs
nor cells composing blast colonies significantly respond to HOXB4
expression (Fig. 3A and Fig. S2). Consistent with BL-CFC data, most
vasculogenic activity was detected in CD41
2 cells (Fig. 3B). In
contrast, most primitive erythropoietic activity was detected in
CD41
+cells (Fig. 3C),as in the yolk sac (YS) [15], supporting the view
that primitive hematopoietic progenitors arise soon after the
developmentofmesoderm[21].Primitiveerythroidcolonyformation
was significantly inhibited by HOXB4 expression (Fig 3C).
Genes expressed in EB6 subpopulations
RT-PCR was performed on cDNAs prepared from fractionated
EB6 cells. Consistent with recently published data[14], all genes
examined, including Runx1, Scl, Gata1,a n dGata2, were expressed in
c-Kit
+CD41
+ c e l l s( F i g .S 3 ) ,s u g g e s t i n gt h a tt h i sp o p u l a t i o na tt h i s
developmental stage is already in the process of establishing definitive
hematopoiesis. Expression of Gata1, b-H1 globin (Hbb-bh1), and b-
major globin (Hbb-b1), detected in c-Kit
2CD41
+ and c-Kit
+CD41
+
cells, supports observations that these two populations contain
primitive erythrocyte precursors (EryPs). Flk1 expression with faint
Brachyury expression in both c-Kit
+CD41
2 cells and c-Kit
+CD41
+
cells implies that these populations are the immediate progeny of
mesodermal precursors. Although low levels of endogenous mouse
HoxB4 expression were detected in c-Kit
+CD41
+ cells, higher
expression levels might be required for generation of HSCs.
Cell surface markers on long-term repopulating cells
derived from EB cells
In order to define HSC phenotypes just before transplantation,
CD41
+ EB6 cells were co-cultured with OP9 cells and were induced
Figure 1. Study design. (A) iHOXB4 ESCs were differentiated into EBs for 6 days in the presence of Dox. (B) Dissociated EB cells were analyzed and
sorted by flow cytometry (FC). EB cells or their subpopulations were co-cultured with OP9 cells for 4 days in the presence or absence of Dox. (C) Co-
cultured cells were analyzed and GFP
+ cells were sorted by FC when HOXB4 expression was turned on. Regardless of HOXB4 status in co-cultures, FC
sorting was performed on co-cultured cells based on forward and side scatters and on surface markers. Sorted cells were subjected to long-term
reconstitution assays. The sorting process turned out to be useful for cell counts, removal of dead cells, and elimination of the remaining Dox.
doi:10.1371/journal.pone.0004820.g001
Pre-HSCs and Embryonic HSCs
PLoS ONE | www.plosone.org 2 March 2009 | Volume 4 | Issue 3 | e4820toexpressHOXB4.HOXB4-expressingcells,detectedasGFP
+cells,
were analyzed for expression of cell surface markers. GFP
+ cells were
fractionated based on expression of CD41, c-Kit, CD34, or CD45 by
flow cytometry (Fig. 4A) and were transplanted into lethally
irradiated mice with rescue cells (Table S2). Analysis of recipient
mice 16 weeks after transplantation showed that CD41
+ cells, c-Kit
+
cells, CD34
+ cells, and CD45
2 cells were enriched in long-term
repopulating activity (Fig. 4B). Myeloid lineage was predominantly
reconstituted in all cases. Numbers of CD41
+,c - K i t
+,a n dC D 3 4
+
cellsapparentlydecreasedintheabsenceofHOXB4expression(data
not shown). These data indicate that HOXB4 expression selectively
maintains the c-Kit
+CD41
+ CD45
2 phenotype and up-regulates
CD34 expression during the co-culture period. It is known that fetal
liver HSCs express CD34 antigen while adult bone marrow HSCs
barely express CD34 antigen [22,23]. These data suggest that ESC-
derived HSCs remain phenotypically immature.
Figure 2. EB6 subpopulations with the potential of giving rise to HSCs. (A) Data from flow cytometry analysis show the expression of CD41,
CD45, c-Kit, and CD34 in EB6 cells. The sorting gates for CD41
2 or CD41
+ cells, c-Kit
+CD41
+ or c-Kit
2CD41
+ cells, and CD34
+ CD41
+ or CD34
2CD41
+
cells are indicated as squares. (B) EB6 cells were fractionated based on expression of CD41, c-Kit, and CD34, co-cultured with OP9 cells for 4 days,
sorted for GFP+ cells, and transplanted into lethally irradiated mice. HOXB4 expression was maintained from in vitro co-culture through in vivo
repopulation. Recipient mice were analyzed 16 weeks after transplantation. Over 95% of reconstituted blood cells were of myeloid lineage in all cases
(data not shown). Two independent experiments gave similar results. Data from one experiment are shown. See Table S1 for the number of
transplanted cells from each subpopulation.
doi:10.1371/journal.pone.0004820.g002
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We observed that c-Kit
+CD41
+ cells had accumulated in the
bone marrow of recipient mice when analyzed 18 weeks after
transplantation (Fig. S4). We attempted to shut HOXB4
expression off in recipient mice from 8 to 14 weeks after
transplantation by letting them drink water containing 100 mg/
ml of Dox. Analysis of peripheral blood cells from these mice
showed that GFP
+ cells became undetectable and that B- and T-
lymphoid lineage reconstitution was significantly improved.
Myeloid lineage reconstitution, contrariwise, was reduced, with
decreases in total chimerism (data not shown). After GFP
+ bone
marrow cells were isolated from other mice reconstituted with
ESC-derived cells, 1.2610
5 GFP
+ cells together with 2610
5 rescue
cells was transplanted into each of 6 lethally irradiated mice, of
which 3 were given Dox and 3 were not. Of the 3 recipients given
Dox, 2 mice showed 0.8% and 15% chimerism, with respectively
46 : 54% and 50 : 50% myeloid : lymphoid lineages. Of the 3
recipients not given Dox, 4 mice showed 45% and 83% chimerism
with almost exclusively myeloid lineage. These results support the
hypothesis that HOXB4 expression negatively affects lymphoid
differentiation and positively affects repopulating activity in ES-
derived HSCs [11], effects not seen in adult HSCs [24].
HOXB4 target genes in HSC development
Our last experiments compared gene expression profiling among
c-Kit
+CD41
+ EB6 cells (cells with the potential to give rise to HSCs),
c-Kit
+CD41
+ cells after co-culture with HOXB4 expression
(repopulating cells), and c-Kit
+CD41
+ cells after co-culture without
HOXB4 expression (non-repopulating cells). We attempted to
identify candidate genes whose expression is up- or down-regulated
by HOXB4, among which might exist important genes that control
the early development of HSCs. To verify the Tet-off strategy,
HOXB4 expression was examined in these 3 populations and in
ESCs maintained in the presence of Dox (ESCs without HOXB4
expression). As expected, HOXB4 expression was only detected in c-
Kit
+CD41
+ EB6 cells after co-culture without Dox (Fig. S5).
Microarray analysis was performed on cDNAs prepared from c-
Kit
+CD41
+ EB6 cells without HOXB4 expression andc-Kit
+CD41
+
cells after co-culturewith or without HOXB4 expression. In order to
focus on genes up- and down-regulated by HOXB4 expression, we
employed stringent criteria (Legends, Tables S3 and S4). Genes with
5-fold or more difference in gene chip scores between c-Kit
+CD41
+
cells after co-culture withHOXB4 expressionand c-Kit
+CD41
+cells
without HOXB4 expression were selected.
After selection, 294 and 115 probes, respectively, remained for
HOXB4 up- and down-regulated genes. We next examined
whether these selected genes are expressed in HSCs via gene
expression profiling of adult HSCs. HSC-expressing genes shared
200 of 294 probes for HOXB4 up-regulated genes. Of great
interest is that CD34, CD150 (Slamf1), c-Mpl, integrin a4 and a6
(Itga4 and 6), and transforming growth factor b type II receptor (Tgfbr2)
were among them. On the other hand, 58 of 115 probes for down-
regulated genes by HOXB4 were not detected on adult HSC
Figure 3. Hemangioblastic, endothelial, and primitive erythro-
cytic potentials among EB6 subpopulations. Colony forming
abilities in unfractionated, c-Kit
2CD41
2, c-Kit
+CD41
2, c-Kit
2CD41
+,o rc -
Kit
+CD41
+ EB6 cells were examined in quadruplicate. (A) Blast colony-
forming assays were performed. (B) Vascular endothelial progenitors
(EP) were detected by the OP9 co-culture system with cytokines as
previously described [20]. (C) Erythroid colonies were detected by
methylcellulose colony assays. Detected erythroid colonies contained
primitive erythrocytes as identified by b-H1 globin expression (data not
shown). Kruskal-Wallis testing was performed for statistical analysis.
doi:10.1371/journal.pone.0004820.g003
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regulated adult HSC-unrelated genes are listed in Tables S3 and
S4 and are also schematically presented as a heat map in Fig. 5A.
The overall similarity in the heat map between the EB6 and the
HOXB4-off samples suggests that these data represent the effect of
enforced expression of HOXB4. RT-PCR analysis showed that the
expression levels of CD150 and c-Mpl were significantly higher in
HOXB4-on c-Kit
+CD41
+ cells than in HOXB4-off c-Kit
+CD41
+
cells, and that the expression levels of bh1-globin (Hbb-bh1)a n dLin28
were significantly lower in HOXB4-on c-Kit
+CD41
+ cells than in
HOXB4-off c-Kit
+CD41
+ cells (Fig. 5B). A marked increase in
CD34
+ repopulating cells (Fig. 4) and a marked decreaseinprimitive
erythroid progenitors (Fig. 3) with HOXB4 expression were
consistent with the gene expression profiling data.
A number of genes are implicated as playing important roles in
the generation of HSCs. According to our microarray data,
significant levels of Scl, Runx1, Gata2, or Lmo2, were expressed in
c-Kit
+CD41
+ cells, but induced HOXB4 expression did not
change their expression levels. Expression levels of Cdx1 and
Cdx4 remained low in c-Kit
+CD41
+ cells regardless of HOXB4
expression.
Discussion
This study demonstrates that pre-HSCs, perhaps conceptually
relevant to hemogenic endothelium [25], can be prospectively
isolated from developing mouse EBs. Pre-HSCs were unable to
engraft and to reconstitute the hematopoietic system in lethally
Figure 4. Surface markers of embryonic HSCs generated from EB6 cells in vitro. (A) CD41
+ EB6 cells were co-cultured with OP9 cells in the
absence of Dox for 4 days. Cells collected from the co-cultures were analyzed by flow cytometry. HOXB4-expressing cells were detected by GFP
expression. Data show the expression of CD41, c-Kit, CD34, and CD45 in GFP
+ cells. The sorting gates for CD41
2 or CD41
+ cells, c-Kit
2 or c-Kit
+ cells,
CD34
2 or CD34
+ cells, and CD45
2 or CD45
+ cells are shown as squares. (B) Co-cultured cells were fractionated based on expression of CD41, c-Kit,
CD34, and CD45, and were transplanted into lethally irradiated mice. Recipient mice were analyzed 16 weeks after transplantation. Over 95% of
reconstituted blood cells were of myeloid lineage in all cases (data not shown). Two independent experiments gave similar results. Data from one
experiment are shown. See Table S2 for the number of transplanted cells for each subpopulation.
doi:10.1371/journal.pone.0004820.g004
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acquire both engraftment and repopulating capacities. This
developmental process was driven or enhanced by enforced
expression of HOXB4. Contrary to previous studies [11], HOXB4
had to be continuously expressed in vivo after transplantation to
maintain long-term repopulation in this study. When HOXB4
expression was turned off in some reconstituted mice, myeloid
reconstitution level was decreased while B- and T-lymphoid
reconstitution levels were increased. As a result, the total
chimerism was gradually reduced (data not shown). We used a
Tet-off system while Kyba et al. used a Tet-on system. An
explanation for this discrepancy may be that Tet-on systems are
‘‘leaky’’ by comparison with Tet-off systems, permitting weak
persistent expression of HOXB4 even after turn-off in the work of
Kyba et al. Long-term repopulating cells generated from pre-HSCs
by OP9 co-culture and HOXB4 expression persistently showed
low levels of long-term reconstitution. When 10
5 adult bone
marrow cells, instead of Sca-1
2 rescue cells, were used as
competitor cells, reconstitution became undetectable (data not
shown). A similar property has been observed for HSCs from the
YS and P-Sp/AGM region. We operationally called these HSCs
with low repopulating potential embryonic HSCs.
As previously noticed [11], HOXB4 overexpression seemed to
have prevented lymphoid reconstitution, with long-term reconsti-
tution mainly myeloid in this study. Multilineage reconstitution
has been a criterion for HSCs. However, myeloid reconstitution
may be more reliable than lymphoid reconstitution as a marker of
HSC activity because short-lived granulocytes are never detectable
in the circulation for long unless they are continuously supplied by
engrafted HSCs.
Pre-HSCs and embryonic HSCs are distinct populations in
functionand geneexpression profiling, buttheyboth exhibitedthec-
Kit
+CD41
+CD45
2 phenotype. Since c-Kit is already expressed in a
significant proportion of undifferentiated ESCs and in most YS, P-
Sp/AGM, fetal liver, and adult bone marrow HSCs [6,26,27,28],
the maintenance of this receptor tyrosine kinase may be crucial for
the development of HSCs from the internal cell mass.
CD41 marks both primitive and definitive hematopoiesis
[15,16,17,18]. The developmental wave of definitive but transient
hematopoiesis clearly differs from that of HSCs [1,2]. Whether
CD41 also marks HSCs in their early development has been
uncertain. In this study, pre-HSCs and primitive erythroid
progenitors were detected among CD41
+ cells (Figs. 2B, 3C). In
contrast, hemangioblastic and vasculogenic activities were princi-
pally detected in CD41
2 cells.
Hemangioblasts are thought to play a major role in initiation of
primitive and definitive hematopoiesis [3]. HSCs have been
generally believed to arise from hemangioblasts [7]. Unlike previous
studies[3], our blast colony assays were performed on EB6 cells
instead of EB3.0 or 3.5 cells. This might be the reason that pre-HSC
and hemangioblast activities were detected in the separated
populations. Pre-HSCs may develop closely associated with
hemangioblasts because these two types of cells arise from common
mesodermal precursors at a veryearly point.It isimportant to clarify
at which stage these cell classes separate from one another during
development. Our data suggest that pre-HSCs are separated from
hemangioblasts as soon as they arise. The possibility exists that pre-
HSCs initially develop through hemangioblasts, but soon thereafter
these two types of cells become distinct from one another.
Alternatively, HSCs develop independent of hemangioblasts. Since
in vitro differentiation of ESCs along the blood lineage mostly mimics
YS hematopoiesis [29], it is possible that pre-HSCs arise in close
association with YS development. In this case, pre-HSCs presum-
ably are unable efficiently to differentiate into embryonic HSCs in
the YS microenvironment, but, after migration, are able to do so in
particular developmental niches like the P-Sp/AGM region [4,5]
and the fetal liver microenvironment.
Although fetal and adult HSCs express CD45, pre-HSCs and
embryonic HSCs were shown not to express CD45. Most HSCs
from the YS and P-Sp/AGM region at E10.5 or earlier do not
express CD45 [19,30]. In this regard, CD45 is a late maturation
marker of HSCs whereas CD41 is an early maturation marker of
HSCs. Identification and characterization of c-Kit
+CD41
+CD45
2
pre-HSCs and embryonic HSCs in early developing embryos will
clarify the significance of changes in HSC phenotype.
Figure 5. Heat map of differentially expressed genes. (A)
Microarray analysis was performed on cDNAs from c-Kit
+CD41
+ EB6 cells
without HOXB4 expression, c-Kit
+CD41
+ cells after co-culture without
HOXB4 expression, and c-Kit
+CD41
+ cells after co-culture with HOXB4
expression. The finally selected 223 genes are shown in this graph (for
selection criteria, see Legend, Table S3). Red indicates genes up-
regulated 5-fold or more. Blue indicates genes down-regulated 5-fold or
more. (B) Real-time PCR was performed on normalized cDNA from the
cells described above, from ESCs maintained without HOXB4 expres-
sion, and from CD34
2KSL cells from adult bone marrow. The mean plus
or minus 1SD (n=3) is shown for 4 representative genes.
doi:10.1371/journal.pone.0004820.g005
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If other HSC inducers are indentified among such molecules,
more efficient generation of HSCs should become possible. A large
number of candidate target genes has been reported recently [31].
Unfortunately, these expressed genes were not always identified
among populations properly enriched in HSC activity. We
therefore used c-Kit
+CD41
+ cells from which HSC activity
emerged after HOXB4 expression was turned on.
Among a number of candidate genes obtained in this study were
many genes known to be expressed in adult HSCs (Table S3). Of
special note is that CD34, CD150,a n dc-Mpl are up-regulated in the
transition of pre-HSCs to embryonic HSCs. Only some pre-HSCs
expressed CD34, but all embryonic HSCs derived from pre-HSCs
expressed CD34 (Fig. 4). That CD34 is expressed in YS and P-Sp/
AGM HSCs [6,32] supports the inference that all these cells are
closely related. CD150, which is expressed from fetal HSCs to adult
HSCs, is a new HSC marker [33,34]. c-Mpl, the receptor for TPO,
is expressed in most fetal and adult HSCs. Although the function of
CD34, CD150, or c-Mpl is not essential for the development of
HSCs [12,35,36], it is suggested that these HSC markers begin to be
expressed at the embryonic HSC stage. CD34, CD150, and c-Mpl
could be good candidates for the earliest markers during HSC
development.Since manyintracellularmolecules (e.g., angiopoietin 1
and myeloperoxidase) were also up-regulated, they might also serve
as markers for embryonic HSCs. Angiopoietin 1, secreted by HSCs
in the P-Sp/AGM region, fetal liver, and adult bone marrow, has
been suggested to promote angiogenesis [37]. High levels of
expression of these molecules might be tightly associated with
commitment to HSC lineage. The origin of HSCs – YS or P-Sp/
AGM region – has been debated for a very long time. It is difficult to
determine precisely which site is the first origin of HSCs because in
the mouse embryo the P-Sp/AGM region does not existatE7, when
the YS begins to appear. A combination of markers listed in this
study should be useful for in vivo detection of embryonic HSCs.
Fetal and adult HSCs are functionally distinct [38,39]. Pre-HSCs
and embryonic HSCs are functionally different from fetal and adult
HSCs. Our working model for HSC development is presented in
Fig. 6. We propose that pre-HSCs which arise from mesoderm,
possibly independent of hemangioblasts, give rise to embryonic
HSCswhichsubsequentlygiverisetofetalandadultHSCs.Whether
all adult HSCs are generated by fetal HSCs remains uncertain, as
recently suggested [40]. These processes should take place in
spatially and temporally established niches in developing embryos.
Certainly much more work is required, but identification and
characterization of pre-HSCs and embryonic HSCs in developing
embryos are central to validation of this model.
Embryonic stem cells (ESCs) hold great promise to innovate a
variety of new therapies for regenerative medicine because of their
potential of differentiating into all sorts of adult cells. The key to
success in stem cell therapy is to establish methods of properly
differentiating ESCs into any particular type of tissue-specific stem
cells. Recent establishment of induced pluripotent stem cell lines
[41,42] demands more such protocols. In order to generate HSCs
from ESCs efficiently in vitro, optimal conditions must be
determined for each developmental step in our model.
Materials and Methods
Mice
129/OlaHsd (129Ola) mice were purchased from Jackson
Laboratory (Bar Harbor, ME). Ly5 congenic C57BL/6 mice (B6-
Ly5.1) were obtained from Sankyo Laboratory Service (Tsukuba,
Japan). 129Ola and B6-Ly5.1 mice were mated to produce F1
mice (Ly5.16Ly5.2). Mice were maintained in the Institute of
Medical Science University of Tokyo Animal Research Center. All
experiments using mice received approval from the Institute of
Medical Science Animal Experiment Committee.
ESCs
The mouse ES cell line EB3, derived from E14tg2a ESCs, was
maintained without mouse embryonic fibroblasts in Glasgow
minimum essential medium supplemented with 10% fetal calf
serum (FCS) (JRH Bioscience, Lenexa, KS), 0.1 mM 2-mercap-
toethanol (2-ME), 2 mM L-glutamine (L-Gln), 0.1 mM non-
essential amino acids, 1 mM sodium pyruvate (Invitrogen,
Carlsbad, CA), 1,000 U/ml leukemia inhibitory factor (LIF,
Chemicon, Temecula, CA), and 100 U/ml penicillin/streptomy-
cin. For these cultures, a 100 mm-tissue culture dish was used after
coating with 5 ml of 0.1% gelatin in PBS for 10 min at 37uC.
Tet-regulated HOXB4/GFP expression in ESCs
The tetracycline (Tet)-off system was chosen because gene
expression is more strictly controllable in the Tet-off system than
in the Tet-on system [43]. ESCs carrying the Tet-off iHOXB4
expression cassette in the ROSA26 locus (iHOXB4 ESCs) were
made as previously described (Fig. S6) [44].
In vitro ESC differentiation
iHOXB4 ESCs were maintained in the presence of 1 mg/ml
doxycycline (Dox), a tetracycline derivative. To allow ESCs to
differentiate into EBs, ESCs were trypsinized and collected in
complete EB differentiation medium (EBD) [3]. Cells were
transferred into a 100-mm Petri dish at 2610
5 cells per 10 ml
EBD. The medium was changed on day 4 of culture and every 2
days thereafter.
Co-culture with OP9 cells
OP9 cells were maintained in a-MEM containing 15% FCS.
10
5 OP9 cells were plated in each well of a 6-well tissue culture
plate 2 days before starting co-culture. Developed EBs were
treated with 0.25% trypsin for 4 min at 37uC and were disrupted
to yield single cells. Co-cultures were employed with IMDM
containing 20 ng/ml mouse stem cell factor (SCF) and 20 ng/ml
human thrombopoietin (TPO), 10% FCS, 2 mM L-Gln, 0.1 mM
2-ME, and 100 U/ml penicillin/streptomycin. On specified days
of co-culture, cells were recovered from the culture dishes for
analysis and sorting on a flow cytometer.
Flow cytometry analysis and sorting
ESCs, EB cells, and cells after OP9 co-culture were stained with
phycoerythrin-conjugated (PE-) anti-Flk-1 (eBioscience, San
Figure 6. A stepwise developmental model for HSCs. We
propose a working model for HSC development. Pre-HSCs originate
from mesoderm, possibly independent of hemangioblasts; pre-HSC
give rise to embryonic HSCs in particular niches in the YS or P-Sp/AGM
region; embryonic HSCs give rise to fetal and adult HSCs in particular
niches in the fetal liver and bone marrow.
doi:10.1371/journal.pone.0004820.g006
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biotinylated anti-CD34, PE-anti-CD41, and APC-anti-c-Kit
antibodies (BD Biosciences, San Jose, CA) on ice for 30 min.
Streptavidin-APC-Cy7 (BD Biosciences) was used for detection of
biotinylated antibody. Analysis and sorting were performed on a
MoFlo (DAKO, Glostrup, Denmark).
Methylcellulose colony assays
Cells were cultured in 1% methylcellulose containing 30% FCS,
1% bovine serumalbumin, 2 mML-glutamine,and 0.05 mM2-ME.
For colony assays, 10 ng/ml mouse interleukin-3, 10 ng/ml SCF,
2 U/ml human erythropoietin, and 50 ng/ml TPO were included.
Cells were incubated at 37uC in a humidified atmosphere with 5%
CO2 in air. Colonies were counted on day 10 of culture and
individually picked up. Each colony was cytocentrifuged onto a glass
slide for morphological examination with May-Gruenwald-Giemsa
staining. Primitive erythroid colonies were counted on day 3 of
culture. Blast colony assays were performed as previously described
[16]. In brief, cells were cultured in IMDM containing 1%
methylcellulose, 10% FCS, 4.5610
24 M monothiolglycerol, 1% L-
Gln, 25 mg/ml ascorbic acid, 300 mg/ml human saturated transfer-
rin, 5 ng/mlvascular endothelialgrowthfactor, 100 ng/ml SCF, and
5 ng/ml IL-6. Blast colonies were counted on day 4 of culture.
Long-term reconstitution assays
2- to 3-month-old B6-Ly5.16129Ola F1 mice (Ly5.1/Ly5.2)
were irradiated at a dose of 900 cGy. ES-derived cells (Ly5.2) were
transplanted into these mice (Ly5.1/ly5.2) along with 3610
5 Sca-
1-depleted (Sca-1
2) bone marrow cells from B6-Ly5.16129Ola F1
mice as rescue cells. To prepare Sca-1
2 cells, mononucleated cells
were obtained by density gradient centrifugation using Ficoll-
Paque PLUS (Amersham Biosciences, Uppsala, Sweden). Cells
were stained with anti-Sca-1 antibody-conjugated magnetic beads
(Miltenyi Biotec, Bergisch Gladbach, Germany). Sca-1
+ cells were
magnetically depleted using an LD column (Miltenyi Biotec).
Peripheral blood cells from recipient mice were analyzed 4 and
16 weeks after transplantation. After red blood cell lysis, cells were
stained with biotinylated anti-CD45.1 antibody. After washing,
cells were stained with PE-anti-CD4, PE-anti-CD8, APC-anti-Gr-
1, APC-anti-Mac-1, and PE-Cy7-anti-B220 antibodies and with
APC-Cy7-streptavidin. At least 10
5 cells were analyzed, and data
were collected on a FACS Aria (BD Biosciences). Test donor cells’
contribution was detected with the GFP marker. Percentage
chimerism was defined as percentage of GFP
+ cells in peripheral
leukocytes. Test donor cells were considered to have contained
long-term repopulating cells when chimerism was over 0.01%.
RT-PCR
PCR was performed on cDNAs from sorted cells as previously
described [45]. Primers are listed in Table S5. The PCR program
consisted of 38 cycles of 15 sec at 95uC, 15 sec at 56uC, and 20 sec
at 72uC.
Real-time PCR
The PCR primers were designed using a program provided by
Roche (https://www.roche-applied-science.com/sis/rtpcr/upl/
index.jsp). PCR contained normalized cDNAs, Universal Probe
Library Set, and FastStart Universal Probe Master (Roche, Basel,
Switzerland). Quantitative PCR analyses were performed in real-
time using an ABI PRISM 7900HT (Applied Biosystems, Foster
City, CA). The PCR program consisted of 43 cycles of 15 sec at
95uC and 60 sec at 60uC. Each value was divided by the mean
value from HOXB4-off samples to be expressed as fold increase.
Microarray analysis
Total RNA was extracted from 3 sets of cells. The first was c-
Kit
+CD41
+EB6cellsderivedfromiHOXB4ESCswithoutHOXB4
expression. The second and third were c-Kit
+CD41
+ cells after co-
culture with OP9 cells for 4 days with or without HOXB4
expression. To prepare cells in the last 2 groups, c-Kit
+CD41
+
EB6 cells were plated onto a monolayer of OP9 cells and were
cultured either in the presence or absence of Dox for 4 days. c-
Kit
+CD41
+ cells were again separated from the co-cultures by flow
cytometry. To compare gene expression profiles with those of adult
HSCs, CD34
2c-Kit
+Sca-1
+Lineager marker
2 (CD34
2KSL) cells
were isolated from C57BL/6 mice as previously described [26]. In
order to analyze cycling adult HSCs, CD34
2KSL cells were
incubated with 50 ng/ml SCF and 50 ng/ml TPO for 24 hours
[46]. Integrity of RNA was assessed qualitatively on an Agilent 2100
Bioanalyzer (Agilent Technologies, Santa Clara, CA). cDNA was
synthesized with a MessageAmp aRNA Kit (Applied Biosystems). In
vitro transcription and labeling were performed using One-Cycle
Target Labeling and Control Reagents (Affymetrix, Santa Clara,
CA) for ESCs and ESC-derived cells, and using Tow-Cycle Target
Labeling and Control Reagents (Affymetrix) for adult HSCs. The
heat-fragmented probes were hybridized to a Mouse Genome 430
2.0 GeneChip (Affymetrix). The arrays were scanned and analyzed
with the Affymetrix GeneChip System. The relative abundance of
each gene was estimated from the average difference of intensities.
Statistical analysis
Mann-Whitney testing was performed when two groups were
compared. Kruskal-Wallis testing was performed when multiple
groups were compared.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0004820.s001 (0.02 MB PDF)
Table S2
Found at: doi:10.1371/journal.pone.0004820.s002 (0.02 MB PDF)
Table S3
Found at: doi:10.1371/journal.pone.0004820.s003 (0.18 MB PDF)
Table S4
Found at: doi:10.1371/journal.pone.0004820.s004 (0.06 MB PDF)
Table S5
Found at: doi:10.1371/journal.pone.0004820.s005 (0.03 MB PDF)
Figure S1 Effect of HOXB4 expression in generation of CFU-
nmEM and surface marker expression. (A) Data show colony
formation by 1,000 cells derived from EB. 1,000 cells were
obtained from EBs on days 0, 2, 4, 5, 6, and 7 of culture and co-
cultured with OP9 cells for 4 days. Cells collected from the co-
cultures were plated in methylcellulose. HOXB4 expression was
turned off in both OP9 co-cultures and methylcellulose cultures
(HOXB4-off), turned on in both (HOXB4-on), or turned on only
in OP9 co-cultures (HOXB4-on to -off). The number of colonies
was counted and cells composing each colony were morpholog-
ically examined. The graphs show the numbers of neutrophil/
macrophage/erythroblasts/megakaryocyte (nmEM) colonies ex-
tracted from various colonies formed. Continuous expression of
HOXB4 in methylcellulose culture was not necessary for nmEM
colony formation. The number of colonies is the mean from 2
independent experiments. (B) Cell surface markers were examined
during EB formation without HOXB4 expression. Flk-1+ cells
were first detected on day 3 of culture; the proportion of Flk-1+
cells markedly increased on the following day and decreased
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day 5 and day 6, respectively, followed by the appearance of
CD34+ cells. CD45+ cells became detectable after day 6, but
remained low in number. c-Kit+ cells constituted about half of the
cells throughout EB formation regardless of whether HOXB4
expression was induced (data not shown).
Found at: doi:10.1371/journal.pone.0004820.s006 (9.39 MB TIF)
Figure S2 Differentiation potential of individual blast colonies.
Both hematopoietic and endothelial potentials were examined for
individual blast colonies. Blast colonies were formed by whole EB6
cells (Fig. 3A). Colonies were individually picked up from
methylcellulose and co-cultured with OP9 cells in the presence
of vascular endothelial growth factor, stem cell factor, interleukin-
3, TPO, and erythropoietin for 7 days. (A) The summary of
hematopoietic and endothelial potentials detected in individual
blast colonies. (B) Representative photomicrographs show that a
colony consisted of blood cells and CD31-positive vascular
endothelial cells.
Found at: doi:10.1371/journal.pone.0004820.s007 (6.61 MB TIF)
Figure S3 RT-PCR for 4 EB6 cell populations. PCR was
performed on cDNAs prepared from fractionated EB6 cells.
Found at: doi:10.1371/journal.pone.0004820.s008 (3.55 MB TIF)
Figure S4 Analysis of bone marrow cells from recipient mice of
HOXB4-expressing ES-derived cells. c-Kit+CD41+ EB6 cells
were co-cultured with OP9 cells while HOXB4 was enforcedly
expressed. After co-culture with OP9 cells, GFP+ cells and rescue
cells were transplanted into lethally irradiated mice. 18 weeks after
transplantation, bone marrow cells of the recipient mice were
stained with antibodies and analyzed on a flow cytometer. (A–E)
GFP2 cells were derived from rescue cells and possibly from host
cells. (F–J) GFP+ cells were derived from ESCs. GFP2 cells and
GFP+ cells are separately displayed for the expression of Gr-1 and
Mac-1 (A, F), B220 and CD19 (B, G), CD4 and CD8 (C, H), Sca-1
and c-Kit (D, I), and CD41 and CD45 (E, J).
Found at: doi:10.1371/journal.pone.0004820.s009 (1.28 MB TIF)
Figure S5 RT-PCR analysis for induced HOXB4 expression in c-
Kit+CD41+ cells. ESCs were maintained in the presence of Dox (ES
HOXB4-off). After ESCs were differentiated into EB6 cells in the
presence of Dox, c-Kit+CD41+ cells were isolated (c-Kit+CD41+
EB6 HOXB4-off). These cells were co-cultured with OP9 cells inthe
presence or absence of Dox for 4 days, followed by recovery of c-
Kit+CD41+ cells from the co-cultures (c-Kit+CD41+ HOXB4-off
and c-Kit+CD41+ HOXB4-on). These c-Kit+CD41+ cells and
ESCs along with adult bone marrow cells (Total BM) as a negative
controlwereexaminedforHOXB4expressionbyRT-PCRanalysis.
The PCR program consisted of 15 sec at 95uC, 15 sec at 60uC, and
30 sec at 72uC. A total of 42 cycles or 30 cycles was used for
amplification of HOXB4 or Gapdh.
Found at: doi:10.1371/journal.pone.0004820.s010 (9.28 MB TIF)
Figure S6 Tet-off inducible HOXB4/EGFP expression system.
(A) Schematic presentation of the Tet-off HOXB4 gene expression
cassette integrated into the constitutive active ROSA 26 locus on
chromosome 6. HOXB4 cDNA was kindly provided by Dr. K.
Humphries (Terry Fox Laboratory, Vancouver, Canada). The Tet-
off regulated gene expression plasmid comprised a splice-acceptor
(SA) sequence; a loxP-flanked neomycin phosphotransferase gene
(neor) gene, including a polyA signal; the Tet-controlled transcrip-
tional activator (tTA) gene, including a polyA signal; an insulator
sequence; the tTA-responsive element (TRE), followed by the
minimal immediate-early promoter from Cytomegalovirus (CMV);
the rabbit beta-globin 2nd intron; human HOXB4 cDNA; an
internal ribosome entry site (ires); EGFP cDNA; and a polyA signal.
The constructed vector was amplified in E. coli Stabl2 cells
(Invitrogen), purified using a GENOPURE plasmid maxi kit
(Roche), linearized by SwaI digestion, and used to transfect ESCs.
The Tet-regulated HOXB4/EGFP expression cassette was inte-
grated into the constitutively active ROSA26 locus in EB3 cells by
homologous recombination. In brief, EB3 ESCs were electroporated
with the linearized vector and were selected with G418 (150–
200 mg/ml). G418-resistant colonies were picked and ES clones
carrying a targeted integration of the vector in the ROSA26 locus
were identified by long distance-PCR analysis using the following
primers: forward (ROSA26 locus 1st exon), 59-CCTCGGCTAGG-
TAGGGGATCGGGACTCT-39; reverse (neor gene), 59-CGGA-
GAACCTGCGTGCAATCCATCTTGTTC-39; forward (EGFP),
59-GGATCACTCTCGGCATGGACGAGCTGTAC-39; and re-
verse (ROSA26 locus 2nd exon), 59-AGCCTTAAACAAG-
CACTGTCCTGTCCTCAAG-39. The PCR cycles consisted of
one cycle at 94uCf o r1m i n ,3 2c y c l e sa t9 8 uC for 20 s, 66uCf o r
30 s, 68uC for 4 min, and one cycle at 72uC for 10 min. To remove
the loxP-flanked neor gene, Cre recombinase was transiently
expressed in the selected clones by transfection with the pCAG-
cre-IRES-puro plasmid. The resultant ES cell line was named
‘‘inducible HOXB4-EGFP ESCs’’ (iHOXB4 ESCs). (B) In the
absence of doxycycline (Dox), tTA binds to the TRE, resulting in
activation of HOXB4/EGFP transcription. In the presence of Dox,
Dox binds tTA, preventing tTA binding to the TRE. We tested if
this inducible expression system works in HOXB4 ES clones.
Representative results from Western blot analysis for 4 clones are
shown. HOXB4 was not detected when ESCs were cultured in the
presence ofDox.HOXB4 was detected whenESCswere cultured in
the absence of Dox. Anti-FLAG antibody was used to detect
HOXB4. EGFP expression in these ES clones was consistent with
results from Western blots (data not shown).
Found at: doi:10.1371/journal.pone.0004820.s011 (1.10 MB TIF)
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